The most important thing to consider when looking for an updated expiration date is the brand or manufacturer of the at-home COVID test. In some cases, the expiration date for a test may be extended. The FDA released an initial version of this infographicfor 2020. designed to detect only one antigen target, currently either a section of the spike protein or a section of the nucleocapsid protein; more susceptible to changes in performance due to viral mutations, meaning they are more likely to fail to detect new variants. COVID-19 rapid antigen self-tests that are approved in Australia To date, however, no device has been added to the list of authorized devices in Appendix A of the letter of authorization. In certain circumstances, one test type may be recommended over the other. 263a, that meet requirements to perform moderate complexity tests. 5 FDA-Authorized At-Home COVID-19 Tests You Can Buy on Amazon - InStyle 8/24/2021. 263a, that meet requirements to perform moderate complexity tests. These at-home COVID tests have been approved by the FDA | How to buy To see additional authorization documents, such as letters granting EUA amendments or revisions, and a list of other brand names authorized under a specific EUA, select the plus (+) button beside the "Date EUA Issued or Last Updated" for each EUA. People with symptoms that began within the last 7 days. Availability: This test is available online with or without a prescription, SELF explained previously.To get it, you'll first have to fill out a survey to make sure you meet the criteria for . The table includes links to home use instructions for each test. The .gov means its official.Federal government websites often end in .gov or .mil. At-Home COVID-19 tests are hard to find right now - Yahoo! "They wanted it to be better safe than sorry," Morrissey said, "but it's been extended on many of those products, where they're actually good. For more information, including answers to frequently asked general questions about at-home COVID-19 diagnostic tests, visit At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions. Learn More. The prevalence, and remaining unknowns, of the omicron variant have put people on edge and sent them out for testing in numbers that have caused the site at Barnett Park in Orange County to hit capacity hours before the it was scheduled to close two days in a row. COVID-19 Testing Update: Today, our administration announced that beginning January 15, 2022, individuals covered by a health insurance plan who purchase an FDA-approved, over-the-counter COVID-19 . "COVID-19 is characterized by high levels of inflammatory markers, including C-reactive protein (CRP), and increased levels of inflammatory cytokines and chemokines. "There's a page on their website where you can look up by the name of the test, and see what that expiration date extension is," Humm said. RT-PCR = reverse transcriptase polymerase chain reaction; LAMP = loop-mediated isothermal amplification; MALDI-TOF = Matrix Assisted Laser Desorption/Ionization - Time of Flight; TMA = Transcription Mediated Amplification; qSTAR = Selective Temperature Amplification Reaction; CRISPR = clustered regularly interspaced short palindromic repeats; Qualitative detection of RNA from SARS-CoV-2 in pooled samples containing up to [3, 5, or 10, depending on the applicable appendix] individual human anterior nasal swabs placed in a single vial containing transport media after being collected by a healthcare provider (HCP) or self-collected under the supervision of an HCP from any individual, including individuals without symptoms or other reasons to suspect COVID-19, when tested at least once per week as part of a serial testing program. Find All FDA-Approved Home and Lab Tests You can find information about each home or lab test that FDA has approved or cleared by searching FDA's Database of In Vitro Diagnostic (IVD). Seagen back in M&A talks after Merck walked away: WSJ Eli Lilly slashes insulin prices by 70%, caps out-of-pocket costs in major access overhaul FDA hands first emergency authorization to over-the-counter test for both COVID and flu Sanofi, poised to rival Roche in hemophilia, nabs FDA approval for Altuviiio BioCryst hits another hurdle, delays . (File Photo). HCP, Recipients, IFU-ARCHITECT, IFU-Alinityi. In this photo illustration, an at-home COVID-19 test by . Some antibody tests use blood samples from a finger stick. This table includes information about authorized SARS-CoV-2 antigen diagnostic tests that have been authorized individually. The FDA has determined that establishing additional conditions is necessary to mitigate the potential risk of false negative results due to either decreased sensitivity or non-reactivity associated with SARS-CoV-2 viral mutations. dba MicroGen DX, Columbia University Laboratory of Personalized Genomic Medicine, BioFire Respiratory Panel 2.1 (RP2.1) - On March 17, 2021, FDA granted the first marketing authorization using the De Novo review pathway for the. designed to detect two or more viral targets, or sections of the SARS-CoV-2 genome; more likely to continue to perform well when new variants emerge. At-Home OTC COVID-19 Diagnostic Tests | FDA This action is in response to available data about the performance of COVID-19 antigen tests showing that repeat testing after a negative COVID-19 antigen test result increases the chance of an accurate result in people with and without symptoms and could help prevent people from unknowingly spreading the SARS-CoV-2 virus to others. OTC - Over The Counter - Food and Drug Administration Molecular tests are more. On September 23, 2021, the FDA revised the EUAs of certain molecular, antigen, and serology tests to establish additional Conditions of Authorization in response to the continued emergence of new variants of SARS-CoV-2. Authorized devices in the table below are assigned the QKO product code. Before sharing sensitive information, make sure you're on a federal government site. "There's a page on their website where you can look up by the name of the test, and see what that expiration date extension is," Humm said. Before sharing sensitive information, make sure you're on a federal government site. Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs, Remote or Wearable Patient Monitoring Devices EUAs, Ventilators and Ventilator Accessories EUAs, Emergency Use Authorizations for Medical Devices, In Vitro Diagnostics EUAs - Antigen Diagnostic Tests for SARS-CoV-2, Molecular Diagnostic Tests for SARS-CoV-2, Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, Antigen EUA Revisions for Serial (Repeat) Testing, Historical Information about Device Emergency Use Authorizations: In Vitro Diagnostics (IVD), INDICAID COVID-19 Rapid Antigen At-Home Test, Letter Granting EUA Revision(s) (May 12, 2022), Letter Granting EUA Revision(s) (August 12, 2022), Letter Granting EUA Revision(s) (December 22, 2022), Letter Granting EUA Revision(s) (March 7, 2022), Letter Granting EUA Revision(s) (April 28, 2022), Letter Granting EUA Revision(s) (June 24, 2022), Letter Granting EUA Revision(s) (October 14, 2022), Letter Granting EUA Revision(s) (March 29, 2022), Letter Granting EUA Revision(s) (April 4, 2022), Letter Granting EUA Revision(s) (July 8, 2022), Letter Granting EUA Revision(s) (January 11, 2023), Letter Granting EUA Revision(s) (November 4, 2022), Letter Granting EUA Revision(s) (January 20, 2023), Letter Granting EUA Revision(s) (October 15, 2021), Letter Granting EUA Revision(s) (April 20, 2022), Letter Granting EUA Revision(s) (September 2, 2022), Letter Granting EUA Revision(s) (November 18, 2022), Letter Granting EUA Revision(s) (August 24, 2022), Letter Granting EUA Amendment(s) (June 9, 2020), Letter Granting EUA Amendment(s) (July 17, 2020), Viral MutationRevision Letter - September 23, 2021, BD Veritor System for Rapid Detection of SARS-CoV-2, Letter Granting EUA Amendment(s) (July 23, 2020), Letter Granting EUA Revision(s) (December 10, 2021), Letter Granting EUA Revision(s) (January 26, 2021), Letter Granting EUA Revision(s) (February 17, 2022), Letter Granting EUA Revision(s) (April 6, 2021), Letter Granting EUA Revision(s) (January 7, 2022), Letter Granting EUA Revision(s) (February 4, 2022), Letter Granting EUA Revision(s) (November 21, 2022), Letter Granting EUA Revision(s) (March 15, 2021), Letter Granting EUA Revisions(s) (July 16, 2021), Letter Granting EUA Revision(s) (December 2, 2021), Letter Granting EUA Revision(s) (January 17, 2023), VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Reagent Pack, Letter Granting EUA Revision(s) (November 16, 2021), BD Veritor System for Rapid Detection of SARS-CoV-2 & Flu A+B, Letter Granting EUA Revision(s) (July 21, 2022), Letter Granting EUA Revision(s) (September 23, 2022), Letter Granting EUA Revision(s) (December 21, 2022), Letter Granting EUA Revision(s) (July 12 2021), Letter Granting EUA Revision(s) (February 16, 2022), Letter Granting EUA Revision(s) (October 25, 2022), Celltrion DiaTrust COVID-19 Ag Rapid Test, Letter Granting EUA Revision(s) (August 11, 2022), Letter Granting EUA Revision(s) (March 3, 2022), Letter Granting EUA Revision(s) (May 26, 2022), Letter Granting EUA Revision(s) (December 23, 2022), Sienna-Clarity COVID-19 Antigen Rapid Test Cassette, Letter Granting EUA Revision(s) (December 17, 2021), Letter Granting EUA Revision(s) (June 09, 2022), Letter Granting EUA Revision(s) (August 3, 2022), Letter Granting EUA Revision(s) (February 01, 2023), Letter Granting EUA Revision(s) (June 13, 2022), Letter Granting EUA Revision(s) (February 21, 2023), Letter Granting EUA Revision(s) (January 14, 2022), Letter Granting EUA Revision(s) (February 22, 2022), Letter Granting EUA Revision(s) (December 28, 2022), Letter Granting EUA Revision(s)(August 23, 2021), Letter Granting EUA Revision(s) (January 22, 2022), Letter Granting EUA Revisions(s) (June 7, 2022), Letter Granting EUA Revision(s) (August 29, 2022), Letter Granting EUA Revision(s) (September 28, 2022), Letter Granting EUA Revision(s) (Feburary 1, 2022, CLINITEST Rapid COVID-19 Antigen Self-Test, Letter Granting EUA Revision(s) (June 23, 2022, Letter Granting EUA Revision(s) (October 12, 2022), Letter Granting EUA Revision(s) (December 27, 2022), MaximBio ClearDetect COVID-19 Antigen Home Test, Letter Granting EUA Revision(s) (March 30, 2022), Letter Granting EUA Revision(s) (July 22, 2022), Letter Granting EUA Revision(s) (December 16, 2022), Letter Granting EUA Revision(s) (January 09, 2023), Letter Granting EUA Revision(s) (May 4, 2022), Letter Granting EUA Revision(s) (December 2, 2022), Letter Graning EUA Revision(s) (February 24, 2023), ADVIA Centaur SARS-CoV-2 Antigen (CoV2Ag), Letter Granting EUA Revision(s) (August 19, 2022), Letter Granting EUA Revision(s) (October 18, 2022), Speedy Swab Rapid COVID-19 Antigen Self-Test, Letter Granting EUA Revision(s) (August 23, 2022). List of Fda Approved Covid-19 Test Kits for Commercial Use CDC COVID-19 Tests | CDC - Centers for Disease Control and Prevention The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. A COVID-19 test done with a sample of your blood (serology) only detects if your body has developed antibodies in response to the COVID-19 virus. The .gov means its official.Federal government websites often end in .gov or .mil. Coronavirus home test kits: These are the tests available now Since the start of. Here's Why Rapid COVID Tests Are So Expensive and Hard to Find The revised Letter of Authorization establishes one additional Condition of Authorization and also eliminates one Condition of Authorization that is no longer needed. Please read the layout guide and lead section guidelines to ensure the section will still be inclusive of all essential details. 3. USGC Saliva Test Kit, hims/hers Saliva Test Kit, AZOVA At-Home COVID-19 Test Collection Kit, Wellness 4 Humanity SDNA-1000 Saliva Collection Kit, AZOVA P23 At-Home COVID-19 Test Collection Kit, binx health (powered by P23) At-home Saliva COVID-19 Test Collection Kit for the Group Setting, Pooling and Serial Testing Amendment for Certain Molecular Diagnostic Tests for SARS-CoV-2 . People without symptoms. Headline Diagnostic Covid tests fall into two buckets: molecular tests and antigen tests. The site is secure. These EUAs have been issued for each individual test with certain conditions of authorization required of the manufacturer and authorized laboratories. "The dates that were printed were very conservative, but it's been extended on many of those products," Bill Morrissey, the managing pharmacist at Kilgore's Medical Pharmacy in Columbia, said. JYNNEOS Vaccine | Mpox | Poxvirus | CDC If the Expiration Date column says that the shelf-life is "extended," there is a link to "updated expiration dates" where you can find a list of the original expiration dates and the new expiration dates. In Vitro Diagnostics EUAs - Molecular Diagnostic Tests for SARS-CoV-2 | FDA Antigen and Molecular Tests for COVID-19 The diagnostic testing field for COVID-19 is rapidly evolving, with many tests focused on diagnosing patients with active viral infections. Cinnamon is a spice obtained from the inner bark of several tree species from the genus Cinnamomum.Cinnamon is used mainly as an aromatic condiment and flavouring additive in a wide variety of cuisines, sweet and savoury dishes, breakfast cereals, snack foods, bagels, teas, hot chocolate and traditional foods.The aroma and flavour of cinnamon derive from its essential oil and principal . How to Buy COVID-19 Tests Online in 2022 - The Hollywood Reporter M - Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. Tests Used In Clinical Care, Recalls, Market Withdrawals and Safety Alerts, Safety Issue on Magellan Diagnostics LeadCare Testing Systems, enter a search term (for example the type of test, name, company, or other key word) in the blank space, review the listing of products that match your search term, select any products for additional information (including Decision Summaries). View graphs and map for Testing in U.S. for COVID-19. Coronavirus (COVID-19) and Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus (COVID-19) and Medical Devices, Counterfeit At-Home OTC COVID-19 Diagnostic Tests, At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions, Blood Specimen Collection Tube Shortage: Frequently Asked Questions, Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers, Emergency Use Authorization of COVID-19 Tests: Independent Assessment of the FDAs Response, Face Masks, Barrier Face Coverings, Surgical Masks, and Respirators for COVID-19, Medical Device Supply Chain Notifications During the COVID-19 Pandemic, Medical Device Shortages During the COVID-19 Public Health Emergency, Supplies of Medical Devices for COVID-19: Frequently Asked Questions, Medical Device Types to Help Determine Section 506J Notification Obligations, Non-contact Temperature Assessment Devices During the COVID-19 Pandemic, Adverse Event Reporting for Medical Devices Under Emergency Use Authorization (EUA) or Discussed in COVID-19-Related Guidance Documents, Contacts for Medical Devices During the COVID-19 Pandemic, COVID-19 Tests and Collection Kits Authorized by the FDA: Infographic, 63 home collection: Tests and collection kits where samples are collected at home and sent to a lab for processing, 32 pooling: Tests that process samples from multiple people at one time, 55 point-of-care: Tests and rapidly return a result at your doctor's office or other health care setting, 19multi-analyte: Tests that detect the virus that causes COVID-19 and other viruses like flu, 13 at-home: Tests performed at home with a self-collected sample, 38 home collection: Tests and collection kits where samples are collected at home and sent to a lab for processing, 18 pooling: Tests that process samples from multiple people at one time, 17 point-of-care: Tests and rapidly return a result at your doctor's office or other health care setting, 11 multi-analyte: Tests that detect the virus that causes COVID-19 and other viruses like flu, 3 at-home: Tests performed at home with a self-collected sample. On November 1, 2022, the FDA revised the authorized uses and required updates to product labeling regarding repeat, or serial, testing, for all currently authorized SARS-CoV-2 antigen tests. Warner-Lambert, which merged with Pfizer in 2000, . Authorized Tests for COVID-19 Diagnostics - National Institute of Antibody tests should not be used to diagnose a current SARS-CoV-2 infection or COVID-19 and, at this time, should also not be used to check for immunity. Alternate brand name: GoodToKnow COVID-19 Antigen Rapid Test, Alternate brand name: GoToKnow COVID-19 Antigen Rapid Test, Alternate brand name: QuickFinder COVID-19 Antigen Self Test. For more information about how the expiration date is determined and why it may be extended, see the At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions. US Navy mulls adding info warfare specialists on more submarines. Where a test was previously authorized for testing of symptomatic individuals (for example, within the first [number specific to each test] days of symptom onset), the test is now authorized for use at least twice over three days with at least 48 hours between tests. Some diagnostic tests use other samples such as mid-turbinate, nasopharyngeal, oropharyngeal, or saliva samples. 263a, that meet requirements to perform high complexity tests. Sara Humm, the senior planner with the Columbia/Boone County Public Health and Human Services said originally, the at-home tests had an expiration date between four and six months. KBIA | Additional information can be found on the FAQs on Testing for SARS-CoV-2 page. An official website of the United States government, Recalls, Market Withdrawals and Safety Alerts, FDA-authorized at-home COVID-19 diagnostic test, Understanding At-Home OTC COVID-19 Antigen Diagnostic Test Results, Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers, Understanding at-home OTC antigen test results, CLIA (Clinical Laboratory Improvement Amendments). FDA recommends repeating COVID-19 at-home test in 48 hours if negative The Food and Drug Administration yesterday advised people who get a negative result from an at-home COVID-19 antigen test to test themselves again after Headline CDC updates public health guidance for preventing COVID-19 illness Since the start of the pandemic, we authorized over 300 tests and collection kits, including: An official website of the United States government, : In Vitro Diagnostics EUAs - Antigen Diagnostic Tests for SARS-CoV-2 | FDA If potential impacts are identified, the EUA holder must communicate with the FDA and end users about the potential risk that presence of the mutations may have on test performance. FDA: Don't use these particular COVID antigen tests due to - silive Rapid tests detect protein. COVID-19 Tests and Collection Kits Authorized by the FDA The FDA is committed to helping ensure the public has access to a wide variety of test options for COVID-19. As set forth in the September 23, 2021 letter, developers of authorized tests that are within the scope of the revision are now required to routinely monitor emerging viral mutations and their potential impact on the performance of the authorized SARS-CoV-2 test(s). Negative results for severe acute respiratory syndrome coronavirus 2 and influenza B, if it is necessary for patient management, should be confirmed with an authorized molecular test performed in an approved laboratory, the FDA said. In 1947, Salk accepted a professorship at the University of Pittsburgh School of . Fox News Channel's Jesse Watters interviewed DeSantis Tuesday evening to discuss his book as well as his plans moving forward. The test is to be performed two times over three days (serial testing), Alternate brand name: On/go COVID-19 Antigen Self-Test, Alternate brand name: On/Go One COVID-19 Antigen Home Test, Requires a Metrix Reader (sold separately). On April 28, 2020, FDA issued an umbrella EUA for SARS-CoV-2 Antibody Tests (Lateral flow or Enzyme-linked immunosorbent assay (ELISA) tests) that have been evaluated in an independent. Most authorized at-home OTC COVID-19 tests are antigen tests, and there. For more information about each test, including the Letter of Authorization and authorized labeling, see In Vitro Diagnostics EUAs: Tables of IVD EUAs. As set forth in the September 23, 2021 letter, developers of authorized tests that are within the scope of the revision are now required to routinely monitor emerging viral mutations and their potential impact on the performance of the authorized SARS-CoV-2 test(s). COVID-19 Testing Task Force Lab List - California For additional information on reading and understanding your test results, see Understanding At-Home OTC COVID-19 Antigen Diagnostic Test Results. They had the sniffles, and with a grandparent set to visit he wanted to minimize the risk that they were infectious. . The site is secure. Walmart. Most authorized at-home OTC COVID-19 tests are antigen tests, and there are also a small number of authorized at-home OTC COVID-19 molecular tests. vaccines accepted will include FDA approved or authorized and WHO Emergency Use Listing vaccines. Abbott Laboratories - Wikipedia Another way to find the updated list of expiration dates is on the FDA's website. Templates for EUA submissions for several types of COVID-19 tests are available to help facilitate the preparation, submission, and authorization of an EUA request: These templates are part of the Policy for Coronavirus Disease-2019 Tests (Revised),which also includes additional policies specific to this public health emergency. The letter also eliminates a Condition of Authorization concerning the collection of additional . However, antibody test results are not reported on the state's dashboard anyway. This revision is effective as of September 23, 2021 for all EUAs that are within the scope of the revision. W - Patient care settings operating under a CLIA Certificate of Waiver. The site is secure. Using the search box in the EUA tables, you can use keywords to search and filter the type of test or collection kit you are looking for. Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs, Remote or Wearable Patient Monitoring Devices EUAs, Ventilators and Ventilator Accessories EUAs, Emergency Use Authorizations for Medical Devices, In Vitro Diagnostics EUAs - Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Molecular Diagnostic Tests for SARS-CoV-2, Individual EUAs for Serology and Other AdaptiveImmune Response Tests for SARS-CoV-2, Umbrella EUA for Independently Validated Serology Tests for SARS-CoV-2, Historical Information about Device Emergency Use Authorizations: In Vitro Diagnostics (IVD), EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA (IgG), Letter Granting EUA Revision(s) (March 1, 2022), Letter Granting EUA Amendment(s) (May 9, 2020), Letter Granting EUA Amendment(s) (June 22, 2020), Letter Granting EUA Revision(s) (September 18, 2020), Letter Granting EUA Revision(s) (December 1, 2020), Viral Mutation Revision Letter (September 23, 2021), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack, Letter Granting EUA Revision(s) (October 30, 2020), Letter Granting EUA Revision(s) (January 29, 2021), Letter Granting EUA Amendment(s) (July 22, 2020), Letter Granting EUA Revision(s) (October 19, 2020), Letter Granting EUA Revision(s) (October 7, 2021), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack, Letter Granting EUA Revision(s) (May 20, 2020), Letter Granting EUA Revision(s) (October 23, 2020), Letter Granting EUA Amendment(s) (July 21, 2020), Letter Granting EUA Revision(s) (February 25, 2022), New York SARS-CoV Microsphere Immunoassay for Antibody Detection, Letter Granting EUA Amendment(s) (June 4, 2020), Letter Granting EUA Revision(s) (July 13, 2021), COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma), RightSign COVID-19 IgG/IgM Rapid Test Cassette, Letter Granting EUA Amendment(s) (July 23, 2020), Letter Granting EUA Revision(s) (August 31, 2020), Dimension Vista SARS-CoV-2 Total antibody assay (COV2T), Letter Granting EUA Amendment(s) (August 7, 2020), Dimension EXL SARS-CoV-2 Total antibody assay (CV2T), Letter Granting EUA Revision(s) (April 21, 2022), Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit, Letter Granting EUA Amendment(s) (August 3, 2020), Letter Granting EUA Revision(s) (October 17, 2020), LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold), Letter Granting EUA Revision(s) (August 12, 2020), Letter Granting EUA Revision(s) (December 2, 2020), Letter Granting EUA Revision(s) (February 14, 2022), Assure COVID-19 IgG/IgM Rapid Test Device, Letter Granting EUA Revision(s) (January 31, 2022), Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette, Letter Granting EUA Revision(s) (July 12, 2021), Letter Granting EUA Revision(s) (March 9, 2022), BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test, Letter Granting EUA Revision(s) (November 6, 2020), Letter Granting EUA Revision(s) (October 31, 2020), Letter Granting EUA Revision(s) (March 19, 2021), BioCheck SARS-CoV-2 IgG and IgM Combo Test, Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test, Letter Granting EUA Revision(s) (November 2, 2021), Letter Granting EUA Revision(s) (November 19, 2021), BioCheck SARS-CoV-2 IgM Antibody Test Kit, BioCheck SARS-CoV-2 IgG Antibody Test Kit, Letter Granting EUA Revision(s) (November 10, 2020), Letter Granting EUA Revision(s) (November 5, 2021), Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit, OmniPATH COVID-19 Total Antibody ELISA Test, Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2, cPass SARS-CoV-2 Neutralization Antibody Detection Kit, Letter Granting EUA Revision(s) (February 1, 2022), COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit, Letter Granting EUA Revision(s) (May 4, 2021), Letter Granting EUA Revision(s) (February 9, 2022), Letter Granting EUA Revision(s) (August 24, 2022), Innovita 2019-nCoV Ab Test (Colloidal Gold), Letter Granting EUA Revision(s) (June 28, 2021), MidaSpot COVID-19 Antibody Combo Detection Kit, Letter Granting EUA Revision(s) (January 25, 2021), Letter Granting EUA Revision(s) (February 5, 2021), Letter Granting EUA Revision(s) (April 12, 2021), Letter Granting EUA Revision(s) (July 29, 2021), Letter Granting EUA Revision(s) (April 2, 2021), Letter Granting EUA Revision(s) (April 26, 2021), Letter Granting EUA Revision(s) (July 21, 2022), COVID-19 Self-Collected Antibody Test System, Letter Granting EUA Revision(s) (June 24, 2021), ZEUS ELISA SARS-CoV-2 Total Antibody Test System, Letter Granting EUA Revision(s) (February 28, 2022), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Quantitative Reagent Pack used in combination with the VITROS Immunodiagnostic Products Anti- SARS-CoV-2 IgG Quantitative Calibrator, Letter Granting EUA Revisions(s) (September 8, 2021, Letter Granting EUA Revisions(s) (June 29, 2022), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total N Reagent Pack used in combination with the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total N Antibody Calibrators, Letter Granting EUA Revision(s) (August 31, 2022), Diazyme SARS-CoV-2 Neutralizing Antibody CLIA Kit, SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests, IgG, Lateral Flow, Fingerstick Whole Blood, Wadsworth Center, New York State Department of Health, IgM and IgG Lateral Flow, Fingerstick Whole Blood, ThermoGenesis SARS-CoV-2 IgM/IgG Antibody Test Kit, IgM and IgG, Lateral Flow, Fingerstick Whole Blood.